Detalhe da pesquisa
1.
Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase.
Cell Mol Life Sci;
80(5): 132, 2023 Apr 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37185776
2.
ß-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features.
Cancer Cell Int;
22(1): 289, 2022 Sep 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36127671
3.
A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer.
Mol Cancer;
19(1): 161, 2020 11 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33218356
4.
Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
Int J Cancer;
143(8): 1978-1993, 2018 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29744876
5.
Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and p70 Ribosomal S6 Kinase1 (S6K1) Pathways.
J Biol Chem;
290(39): 23553-62, 2015 Sep 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26242912
6.
The retinoic acid derivative, ABPN, inhibits pancreatic cancer through induction of Nrdp1.
Carcinogenesis;
36(12): 1580-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26464195
7.
The diarylheptanoid hirsutenone sensitizes chemoresistant ovarian cancer cells to cisplatin via modulation of apoptosis-inducing factor and X-linked inhibitor of apoptosis.
J Biol Chem;
289(3): 1723-31, 2014 Jan 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24247248
8.
Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission.
J Biol Chem;
288(33): 23740-50, 2013 Aug 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23833193
9.
The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer.
Theranostics;
14(6): 2442-2463, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38646654
10.
Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR.
J Exp Clin Cancer Res;
42(1): 292, 2023 Nov 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37924112
11.
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response.
Oncogene;
41(23): 3289-3297, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35501463
12.
The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells.
Cell Death Discov;
7(1): 354, 2021 Nov 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34775489
13.
C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
Cancer Lett;
447: 141-153, 2019 04 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30703411
14.
Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer.
Cancer Lett;
412: 118-130, 2018 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29080749
15.
Induction of Synthetic Lethality by Natural Compounds Targeting Cancer Signaling.
Curr Pharm Des;
23(29): 4311-4320, 2017 Nov 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28699516
16.
Sulforaphene suppresses growth of colon cancer-derived tumors via induction of glutathione depletion and microtubule depolymerization.
Mol Nutr Food Res;
60(5): 1068-78, 2016 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26918318
17.
Phytochemicals: a multitargeted approach to gynecologic cancer therapy.
Biomed Res Int;
2014: 890141, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25093186
18.
An improved quantitative approach for the assessment of mitochondrial fragmentation in chemoresistant ovarian cancer cells.
PLoS One;
8(9): e74008, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24040144
19.
The mTORC2 component rictor contributes to cisplatin resistance in human ovarian cancer cells.
PLoS One;
8(9): e75455, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24086535
20.
USP8 is a novel target for overcoming gefitinib resistance in lung cancer.
Clin Cancer Res;
19(14): 3894-904, 2013 Jul 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23748694